Skip to main content
Bio-Techne8-K: Succession announcement

Bio-Techne names Steve Crouse President of Diagnostics & Spatial Biology, replacing Dr. Matt McManus effective March 1, 2026.

What happened

The appointment of a new segment president, following the 'without cause' termination of his predecessor, signals a potential strategic shift or performance review within the key Diagnostics and Spatial Biology division.

Source

SEC EDGARFeb 11, 2026

Current report (Form 8-K)

Bio-Techne 8-K

Filing excerpt

On February 11, 2026, Bio-Techne Corporation (the “Company”) announced that Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, will be transitioning from his role, effective March 1, 2026...

sec.gov/Archives/edgar/data/842023/000110465926013412/tech-20260209x8...Read the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Succession announcement

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
Feb 11, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$505K (New Segment President's annual base salary)
Percent
75% (Target annual cash incentive bonus as a percentage of base salary)

Details

CIK
842023
Accession number
0001104659-26-013412
Timeframe
Next quarter
Filing year
2026
Why it matters
Upcoming vendor review window
Signal category
Leadership

Topics and mentions

Technologies

  • Spatial Biology
  • protein analysis
  • immunoassays

Competitors

  • Thermo Fisher Scientific

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
Feb 17, 2026
signal_type
sec-8k
signal_subtype
successionAnnouncement

Use this data

Get every 8-K signal for Bio-Techne and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/995ef64b-f0a3-439c-9b8f-1de95ca28aba returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.

{
  "signal_id": "995ef64b-f0a3-439c-9b8f-1de95ca28aba",
  "signal_type": "sec-8k",
  "signal_subtype": "successionAnnouncement",
  "detected_at": "2026-02-17T09:04:08.072+00:00",
  "company": {
    "name": "Bio-Techne",
    "domain": "bio-techne.com"
  },
  "data": {
    "detail": "The appointment of a new segment president, following the 'without cause' termination of his predecessor, signals a potential strategic shift or performance review within the key Diagnostics and Spatial Biology division. The new leader, with a mandate for growth and innovation, will likely re-evaluate current projects, budgets, and vendor partnerships, creating a window of opportunity for new solution providers.",
    "metrics": {
      "pct": 0.75,
      "timeframe": "next_quarter",
      "pct_context": "Target annual cash incentive bonus as a percentage of base salary",
      "dollar_context": "New Segment President's annual base salary",
      "dollar_millions": 0.505
    },
    "summary": "Bio-Techne names Steve Crouse President of Diagnostics & Spatial Biology, replacing Dr. Matt McManus effective March 1, 2026.",
    "excerpts": "On February 11, 2026, Bio-Techne Corporation (the “Company”) announced that Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, will be transitioning from his role, effective March 1, 2026...",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/842023/000110465926013412/tech-20260209x8k.htm",
    "filing_date": "2026-02-11",
    "filing_year": 2026,
    "sales_relevance": "Upcoming vendor review window",
    "signal_category": "leadership",
    "competitors_mentioned": [
      "Thermo Fisher Scientific"
    ],
    "technologies_mentioned": [
      "Spatial Biology",
      "protein analysis",
      "immunoassays"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.